{"id":10190,"date":"2019-05-14T00:00:56","date_gmt":"2019-05-14T00:00:56","guid":{"rendered":"https:\/\/www.olartemoure.com\/?p=10190"},"modified":"2023-12-06T11:11:57","modified_gmt":"2023-12-06T16:11:57","slug":"biosimilar-market-entry","status":"publish","type":"post","link":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/","title":{"rendered":"Colombia approves \u201cbiosimilar\u201d market entry using alternative way"},"content":{"rendered":"<p>In September 2014, the government of Colombia issued decree 1782 which would allow <a href=\"https:\/\/olartemoure.us12.list-manage.com\/track\/click?u=b44799ae064f26c13005463dc&amp;id=b8aaa1cc41&amp;e=d1cf43e96b\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/olartemoure.us12.list-manage.com\/track\/click?u%3Db44799ae064f26c13005463dc%26id%3Db8aaa1cc41%26e%3Dd1cf43e96b&amp;source=gmail&amp;ust=1557579147123000&amp;usg=AFQjCNEuGTK55lXnwcVhckFEQehoq0xUuA\">the entry of biosimilars to the country<\/a>, i.e., the biotech \u201cgenerics\u201d.<\/p>\n<p>The decree caused quite a controversy in the pharmaceutical sector, reason why Afidro filed a lawsuit before the Council of State in 2016, with the aim of imposing a precautionary measure and not allowing the abbreviated market entry. Afidro stated this route would be risky for the health of Colombians, given it does not require clinical studies to fully guarantee safety, quality, and efficacy of the medications.<\/p>\n<p>After a two year wait, the Council of State made its first pronouncement, through which it authorized the entry of the so-called biosimilars by means of the alleged abbreviated route. The decision is not yet final, but it will be understood as being effective while the case is under review and a final decision is made.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In September 2014, the government of Colombia issued decree 1782 which would allow the entry of biosimilars to the country.<\/p>\n","protected":false},"author":2,"featured_media":10192,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[59,109],"tags":[],"class_list":["post-10190","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletter-en","category-regulatory-affairs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Colombia approves \u201cbiosimilar\u201d market entry using alternative way - OlarteMoure | Intellectual Property<\/title>\n<meta name=\"description\" content=\"In September 2014, the government of Colombia issued decree 1782 which would allow the entry of biosimilars to the country.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Colombia approves \u201cbiosimilar\u201d market entry using alternative way\" \/>\n<meta property=\"og:description\" content=\"In September 2014, the government of Colombia issued decree 1782 which would allow the entry of biosimilars to the country.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/\" \/>\n<meta property=\"og:site_name\" content=\"OlarteMoure | Intellectual Property\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-14T00:00:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-06T16:11:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/05\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Diego Bernal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Diego Bernal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/\"},\"author\":{\"name\":\"Diego Bernal\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/b66ca4b152a396f32fd6e5c48395ce14\"},\"headline\":\"Colombia approves \u201cbiosimilar\u201d market entry using alternative way\",\"datePublished\":\"2019-05-14T00:00:56+00:00\",\"dateModified\":\"2023-12-06T16:11:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/\"},\"wordCount\":153,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg\",\"articleSection\":[\"Newsletter\",\"Regulatory Affairs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/\",\"name\":\"Colombia approves \u201cbiosimilar\u201d market entry using alternative way - OlarteMoure | Intellectual Property\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg\",\"datePublished\":\"2019-05-14T00:00:56+00:00\",\"dateModified\":\"2023-12-06T16:11:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/b66ca4b152a396f32fd6e5c48395ce14\"},\"description\":\"In September 2014, the government of Colombia issued decree 1782 which would allow the entry of biosimilars to the country.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/#primaryimage\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg\",\"contentUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg\",\"width\":800,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/biosimilar-market-entry\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Colombia approves \u201cbiosimilar\u201d market entry using alternative way\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/\",\"name\":\"OlarteMoure | Intellectual Property\",\"description\":\"Firma especializada en Propiedad Intelectual\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/olartemoure.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/b66ca4b152a396f32fd6e5c48395ce14\",\"name\":\"Diego Bernal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g\",\"caption\":\"Diego Bernal\"},\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/author\\\/dsb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Colombia approves \u201cbiosimilar\u201d market entry using alternative way - OlarteMoure | Intellectual Property","description":"In September 2014, the government of Colombia issued decree 1782 which would allow the entry of biosimilars to the country.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/","og_locale":"en_US","og_type":"article","og_title":"Colombia approves \u201cbiosimilar\u201d market entry using alternative way","og_description":"In September 2014, the government of Colombia issued decree 1782 which would allow the entry of biosimilars to the country.","og_url":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/","og_site_name":"OlarteMoure | Intellectual Property","article_published_time":"2019-05-14T00:00:56+00:00","article_modified_time":"2023-12-06T16:11:57+00:00","og_image":[{"width":800,"height":350,"url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/05\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg","type":"image\/jpeg"}],"author":"Diego Bernal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Diego Bernal","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/#article","isPartOf":{"@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/"},"author":{"name":"Diego Bernal","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/b66ca4b152a396f32fd6e5c48395ce14"},"headline":"Colombia approves \u201cbiosimilar\u201d market entry using alternative way","datePublished":"2019-05-14T00:00:56+00:00","dateModified":"2023-12-06T16:11:57+00:00","mainEntityOfPage":{"@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/"},"wordCount":153,"commentCount":0,"image":{"@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/05\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg","articleSection":["Newsletter","Regulatory Affairs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/","url":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/","name":"Colombia approves \u201cbiosimilar\u201d market entry using alternative way - OlarteMoure | Intellectual Property","isPartOf":{"@id":"https:\/\/olartemoure.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/#primaryimage"},"image":{"@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/05\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg","datePublished":"2019-05-14T00:00:56+00:00","dateModified":"2023-12-06T16:11:57+00:00","author":{"@id":"https:\/\/olartemoure.com\/#\/schema\/person\/b66ca4b152a396f32fd6e5c48395ce14"},"description":"In September 2014, the government of Colombia issued decree 1782 which would allow the entry of biosimilars to the country.","breadcrumb":{"@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/#primaryimage","url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/05\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg","contentUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/05\/190506-Imagenes-OMWD-semana-6-10_Mesa-de-trabajo-1-copia.jpg","width":800,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/olartemoure.com\/en\/biosimilar-market-entry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/olartemoure.com\/en\/"},{"@type":"ListItem","position":2,"name":"Colombia approves \u201cbiosimilar\u201d market entry using alternative way"}]},{"@type":"WebSite","@id":"https:\/\/olartemoure.com\/#website","url":"https:\/\/olartemoure.com\/","name":"OlarteMoure | Intellectual Property","description":"Firma especializada en Propiedad Intelectual","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olartemoure.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/b66ca4b152a396f32fd6e5c48395ce14","name":"Diego Bernal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g","caption":"Diego Bernal"},"url":"https:\/\/olartemoure.com\/en\/author\/dsb\/"}]}},"_links":{"self":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/10190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/comments?post=10190"}],"version-history":[{"count":0,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/10190\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media\/10192"}],"wp:attachment":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media?parent=10190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/categories?post=10190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/tags?post=10190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}